Loading stock data…
Henry Schein (HSIC)
$84.29-0.66 (-0.78%)
After Hours$84.29+0.00 (+0.00%)· Last close Jun 29
Henry Schein, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Henry Schein, Inc. in the Healthcare sector is trading at $84.29 with a market capitalization of $9.3B. Wall Street consensus targets $88.07 (15 analysts), implying a +4.5% move over the next 12 months. The stock is currently near its 52-week high of $89.29, remaining 13.8% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.37B↓ | $3.44B↑ | $3.34B↑ | $3.24B↑ | $3.17B |
| Gross Profit | $1.07B↑ | $1.06B↑ | $1.03B↑ | $1.02B↑ | $1.00B |
| Operating Income | $194.00M↑ | $186.00M↓ | $198.00M↑ | $174.00M↓ | $200.00M |
| Net Income | $107.00M↑ | $101.00M | $101.00M↑ | $86.00M↓ | $110.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.32B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.09%
Volume
Today's trading volume
1.08M
Recent News
3 Reasons to Avoid HSIC and 1 Stock to Buy Instead
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7.2% to $81.63 per share while the index has gained 6.2%.
Is Henry Schein Stock Underperforming the Nasdaq?
Henry Schein has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
3 Unpopular Stocks We Approach with Caution
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
How Investors Are Reacting To Henry Schein (HSIC) Upgrade On Dental Strength And Margin Improvements
Earlier this week, BTIG upgraded Henry Schein’s rating, highlighting strong performance in its dental segment and improved profit margins from recent cost-saving efforts. The firm’s commentary suggests that efficiency gains in Henry Schein’s core operations are becoming a more important driver of its overall business profile. We’ll now explore how BTIG’s upgrade, centered on margin improvement and dental strength, may influence Henry Schein’s existing investment narrative. The future of work...
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls